Curcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalization

References

• Aggarwal BB, Harikumar KB. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 41:40–59.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmad A, Schneider BK, et al. 2006. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) Cells. Int J Toxicol. 25:17–23.
   PubMed Web of Science ®Google Scholar
• Ak T, Gülçin I. 2008. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. 174:27–37.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, et al. 2007. Bioavailability of curcumin: Problems and promises. Mol Pharm. 4:807–818.
   PubMed Web of Science ®Google Scholar
• Anand P, Sundaram C, Jhurani S, et al. 2008. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 267:133–164.
   PubMed Web of Science ®Google Scholar
• Androutsopoulos VP, Ruparelia K, Arroo RRJ, et al. 2009. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology. 264:162–170.
   PubMed Web of Science ®Google Scholar
• Andrushchenko VV, Vogel HJ, Prenner EJ. 2007. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. J Pept Sci. 13:37–43.
   PubMed Web of Science ®Google Scholar
• Angius F, Floris A. 2015. Liposomes and MTT cell viability assay: an incompatible affair. Toxicol in Vitro. 29:314–319.
   PubMed Web of Science ®Google Scholar
• Avraamides CJ, Garmy-Susini B, Varner JA. 2008. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 8:604–617.
   PubMed Web of Science ®Google Scholar
• Banfi L, Basso A, Damonte G, et al. 2007. Synthesis and biological evaluation of new conformationally biased integrin ligands based on a tetrahydroazoninone scaffold. Bioorg. Med Chem Lett. 17:1341–1345.
   PubMedGoogle Scholar
• Barry J, Fritz M, Brender JR, et al. 2009. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc. 131:4490–4498.
   PubMed Web of Science ®Google Scholar
• Basu A, Kumar GS. 2014. Elucidating the energetics of the interaction of non-toxic dietary pigment curcumin with human serum albumin: a calorimetric study. J Chem Thermodyn. 70:176–181.
   Web of Science ®Google Scholar
• Baum L, Ng A. 2004. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis. 6:367–377.
   PubMed Web of Science ®Google Scholar
• Belvisi L, Bernardi A, Colombo M, et al. 2006. Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids. Bioorgan Med Chem. 14:169–180.
   PubMed Web of Science ®Google Scholar
• Bernabé-Pineda M, Ramı´rez-Silva MT, Romero-Romo M, et al. 2004. Determination of acidity constants of curcumin in aqueous solutions and apparent rate constant of its decomposition. Spectrochim Acta a. 60:1091–1097.
   PubMed Web of Science ®Google Scholar
• Bush JA, Cheung KJ Jr, Li G. 2001. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res. 271:305–314.
   PubMed Web of Science ®Google Scholar
• Chan KS, Koh CG, Li HY. 2012. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis. 3:e411
   PubMed Web of Science ®Google Scholar
• Chen B, Zhang Y, Wang Y, et al. 2014. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. J Steroid Biochem. 143:11–18.
   Google Scholar
• Chen QY, Lu GH, Wu YQ, et al. 2010. Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep. 23:1285–1292.
   PubMed Web of Science ®Google Scholar
• Choudhuri T, Pal S, Das T, et al. 2005. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem. 280:20059–20068.
   PubMed Web of Science ®Google Scholar
• Colombo G, Curnis F, De Mori GMS, et al. 2002. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. J Biol Chem. 277:47891–47897.
   PubMed Web of Science ®Google Scholar
• Cos S, Sinchez-Barcelb EJ. 1995. Melatonin inhibition of MCF-7 human breast-cancer cells growth: Influence of cell proliferation rate. Cancer Lett. 93:207–212.
   PubMed Web of Science ®Google Scholar
• Creighton CJ, Du Y, Santulli RJ, et al. 2006. Synthesis and biological evaluation of type VI beta-turn templated RGD peptidomimetics . Bioorg Med Chem Lett. 16:3971–3974.
   PubMed Web of Science ®Google Scholar
• Curnis F, Longhi R, Crippa L, et al. 2006. Spontaneous formation of l-isoaspartate and gain of function in fibronectin. J Biol Chem. 281:36466–36476.
   PubMed Web of Science ®Google Scholar
• Egan ME, Pearson M, Weiner SA, et al. 2004. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 304:600–602.
   PubMed Web of Science ®Google Scholar
• El-Sayed A, Futaki S, Harashima H. 2009. Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment. AAPS J. 11:13–22.
   PubMed Web of Science ®Google Scholar
• El-Sayed MEH, Hoffman AS, Stayton PS. 2005. Rational design of composition and activity correlations for pH-sensitive and glutathione-reactive polymer therapeutics. J Control Release. 101:47–58.
   PubMed Web of Science ®Google Scholar
• Gandhy SU, Kim KH, Larsen L, et al. 2012. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer. 12:564.
   PubMed Web of Science ®Google Scholar
• Gentilucci L, Cardillo G, Squassabia F, et al. 2007. Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. Bioorg Med Chem Lett. 17:2329–2333.
   PubMed Web of Science ®Google Scholar
• Gubernator J. 2011. Active methods of drug loading into liposomes: Recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv. 8:565–580.
   PubMed Web of Science ®Google Scholar
• Haspel N, Zanuy D, Nussinov R, et al. 2011. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Biochemistry. 50:1755–1762.
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Gharbi M, Dierckxsens Y, et al. 2014. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med. 14:159
   PubMed Web of Science ®Google Scholar
• Holliday DL, Speirs V. 2011. Choosing the right cell line for breast cancer research. Breast Cancer Res. 13:215
   PubMed Web of Science ®Google Scholar
• Huang HW. 2009. Free energies of molecular bound states in lipid bilayers: Lethal concentrations of antimicrobial peptides. Biophys J. 96:3263–3272.
   PubMed Web of Science ®Google Scholar
• Hung WC, Chen FY, Lee CC, et al. 2008. Membrane-thinning effect of curcumin. Biophys J. 94:4331–4338.
   PubMed Web of Science ®Google Scholar
• Jiang M, Huang O, Zhang X, et al. 2013. Curcumin induces cell death and restores Tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. Molecules. 18:701–720.
   PubMed Web of Science ®Google Scholar
• Kang N, Wang MM, Wang YH, et al. 2014. Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells. Food Chem Toxicol. 67:193–200.
   PubMed Web of Science ®Google Scholar
• Karewicz A, Bielska D, Gzyl-Malcher B, et al. 2011. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf B Biointerfaces. 88:231–239.
   PubMed Web of Science ®Google Scholar
• Khanna D, Sethi G, Seok Ahn K, et al. 2007. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 7:344–351.
   PubMed Web of Science ®Google Scholar
• Kichler A, Leborgne C, März J, et al. 2003. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci USA. 100:1564–1568.
   PubMed Web of Science ®Google Scholar
• Kumar SSD, Mahesh A, Mahadevan S, et al. 2014. Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells. Biochim Biophys Acta. 1840:1913–1922.
   PubMed Web of Science ®Google Scholar
• Kunwar A, Barik A, Pandey R, et al. 2006. Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study. Biochim Biophys Acta. 1760:1513–1520.
   PubMed Web of Science ®Google Scholar
• Leung MHM, Colangelo H, Kee TW. 2008. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir. 24:5672–5675.
   PubMed Web of Science ®Google Scholar
• Li HL, Liu C, de Couto G, et al. 2008. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest. 118:879–893.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen J, Luo S, et al. 2015. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues. Eur J Med Chem. 93:461–469.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng X, Sun Y, et al. 2014. RGD-fatty alcohol-modified docetaxel liposomes improve tumor selectivity in-vivo. Int J Pharm. 468:133–141.
   PubMed Web of Science ®Google Scholar
• Lin L, Hutzen B, Ball S, et al. 2009. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells. Cancer Sci. 100:1719–1727.
   PubMed Web of Science ®Google Scholar
• Loyer P, Bedhouche W, Wei Huang Z, et al. 2013. Degradable and biocompatible nanoparticles decorated with cyclic RGD peptide for efficient drug delivery to hepatoma cells in vitro. Int J Pharm. 454:727–737.
   PubMed Web of Science ®Google Scholar
• Marchand-Brynaert J, Detrait E, Noiset O, et al. 1999. Biological evaluation of RGD peptidomimetics, designed for the covalent derivatization of cell culture substrata, as potential promotors of cellular adhesion. Biomaterials. 20:1773–1782.
   PubMed Web of Science ®Google Scholar
• Marchini M, Mingozzi M, Colombo R, et al. 2012. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands. Chemistry. 18:6195–6207.
   PubMed Web of Science ®Google Scholar
• McNally SJ, Harrison EM, Ross JA, et al. 2007. Curcumin induces hemeoxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med. 19:165–172.
   PubMed Web of Science ®Google Scholar
• Mehta K, Pantazis P, McQueen T, et al. 1997. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs. 8:470–481.
   PubMed Web of Science ®Google Scholar
• Midoux P, Pichon C, Yaouanc JJ, et al. 2009. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol. 157:166–178.
   PubMed Web of Science ®Google Scholar
• Mohankumar K, Pajaniradje S, Sridharan S, et al. 2014. Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin-an in vitro and in silico approach. Chem Biol Interact. 210:51–63.
   PubMed Web of Science ®Google Scholar
• Muller A, Schumann F, Koksch M, et al. 1997. Synthesis of cyclic RGD-peptides containing G-amino acids. Lett Pept Sci. 4:275–281.
   Google Scholar
• Naik S, Patel D, Chuttani K, et al. 2012. In-vitro mechanistic study of cell death and in-vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancer. Nanomed Nanotechnol. 8:951–962.
   PubMed Web of Science ®Google Scholar
• Nava G, Piñón E, Mendoza L, et al. 2011. Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine. Pharmaceutics. 3:954–970.
   PubMedGoogle Scholar
• Ogunsola OA, Kraeling ME, Zhong S, et al. 2012. Structural analysis of ‘‘flexible’’ liposome formulations: new insights into the skin-penetrating ability of soft nanostructures. Commun Soft Matter. 8:10226.
   Web of Science ®Google Scholar
• Palange AL, Di Mascolo D, Singh J, et al. 2012. Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatment. Front Oncol. 2: (art 161), doi: 10.3389/fonc.2012.00161.
   PubMedGoogle Scholar
• Particle sciences, drug development services; technical brief, 2012, Vol. 2. An overview of the zeta potential, [cited 2016 Jan 21]. Available from: http://www.particlesciences.com/news/technical-briefs/2012/overview-of-zeta-potential.html.
   Google Scholar
• Patel PR, Conrad Kiser R, Lu YY, et al. 2012. Synthesis and cell adhesive properties of linear and cyclic RGD functionalized polynorbornene thin films. Biomacromolecules. 13:2546–2553.
   PubMed Web of Science ®Google Scholar
• Patel R, Singh SK, Singh S, et al. 2009. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res. 1:71–80.
   Google Scholar
• Patil YP, Jadhav S. 2014. Novel methods for liposome preparation. Chem Phys Lipids. 177:8–18.
   PubMed Web of Science ®Google Scholar
• Prasada CP, Ratha G, Mathurc S, et al. 2009. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact. 181:263–271.
   PubMed Web of Science ®Google Scholar
• Qin H, Liu J, Zhang Z, et al. 2014. In situ electrochemical assessment of cytotoxicity of chlorophenols in MCF-7 and HeLa cells. Anal Biochem. 462:60–66.
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Rodriguez S, Ramachandran R, et al. 2005. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25:3293–3302.
   PubMed Web of Science ®Google Scholar
• Ramachandran C, You W. 1999. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat. 54:269–278.
   PubMed Web of Science ®Google Scholar
• Ranjan AP, Mukerjee A, Helson L, et al. 2013. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Res. 33:3603–3610.
   PubMed Web of Science ®Google Scholar
• Ravindran J, Prasad S, Aggarwal BB. 2009. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS J. 11:495–510.
   PubMed Web of Science ®Google Scholar
• Roxin A, Zheng G. 2012. Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides. Future Med Chem. 4:1601–1618.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Bhatia SN, Sailor MJ. 2010. Targeting of drugs and nanoparticles to tumors. J Cell Biol. 188:759–768.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Teesalu T, Sugahara K. inventors. 2009. Burnham Institute for Medical Research, assignee. Methods and compositions related to peptides and proteins with C-terminal elements. United States patent US 20090226372 A1. Sep 10.
   Google Scholar
• Sahebkar A, Chew GT, Watts GF. 2014. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res. 56:47–66.
   PubMed Web of Science ®Google Scholar
• Sanmukhani J, Satodia V, Trivedi J, et al. 2014. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 28:579–585.
   PubMed Web of Science ®Google Scholar
• Santo RD, Costi R, Artico M, et al. 2003. HIV-1 integrase inhibitors that block HIV-1 replication in infected cells. Planning synthetic derivatives from natural products. Pure Appl Chem. 75:195–206.
   Web of Science ®Google Scholar
• Sharma PK, Varadan VV, Varadan VK. 2002. Effect of Tween-80 on the control of particle size and shrinkage properties of nanoscale α-alumina synthesized by sol-gel processing. J Am Ceram Soc. 85:2584–2586.
   Web of Science ®Google Scholar
• Stephenson JM, Banerjee S, Saxena NK, et al. 2002. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int J Cancer. 101:409–414.
   PubMed Web of Science ®Google Scholar
• Sun SH, Huang HC, Huang C, et al. 2012. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. Eur J Pharmacol. 690:22–30.
   PubMed Web of Science ®Google Scholar
• Sutherland RL, Hall RE, Taylor IW. 1983. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 43:3998–4006.
   PubMed Web of Science ®Google Scholar
• Taylor RA, Leonard MC. 2011. Curcumin for inflammatory bowel disease: a review of human studies. Altern Med Rev. 16:152–156.
   PubMedGoogle Scholar
• Teesalu T, Sugahara KN, Ramana Kotamraju V, et al. 2009. C-End rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci USA. 106:16157–16162.
   PubMed Web of Science ®Google Scholar
• Thompson EW, Paik S, Brünner N, et al. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol. 150:534–544.
   PubMed Web of Science ®Google Scholar
• Thulasiraman P, McAndrews DJ, Mohiudddin IQ. 2014. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells. BMC Cancer. 14:724
   PubMed Web of Science ®Google Scholar
• Tong D, Czerwenka K, Sedlak J, et al. 1999. Association of in-vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Tr. 56:91–97.
   PubMed Web of Science ®Google Scholar
• Tønnesen HH. 2006. Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules. Studies of curcumin and curcuminoids. XXX. Pharmazie. 61:696–700.
   PubMed Web of Science ®Google Scholar
• Tu YF, Kaipparettu BA, Ma Y, et al. 2011. Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta. 1807:1125–1132.
   PubMed Web of Science ®Google Scholar
• Updike MS, Davis ME, Wang LS, et al. 2005. Decreased MCF-7 breast cancer cell proliferation by serum from a selected line of beef cattle. Anticancer Res. 25:871–874.
   PubMed Web of Science ®Google Scholar
• Vander Kooi CW, Jusino MA, Perman B, et al. 2007. Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci USA. 104:6152–6157.
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Scholte M, Storm G, et al. 2010. Endosomal escape pathways for delivery of biologicals. J Control Release. 151:220–228.
   PubMed Web of Science ®Google Scholar
• von Wronski MA, Raju N, Pillai R, et al. 2006. Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J Biol Chem. 281:5702–5710.
   PubMed Web of Science ®Google Scholar
• Voss MJ, Möller MF, Powe DG, et al. 2011. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism. BMC Cancer. 11:158.
   PubMed Web of Science ®Google Scholar
• Wang F, Chen L, Zhang R, et al. 2014. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. J Control Release. 196:222–233.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Pan MH, Cheng AL, et al. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 15:1867–1876.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Okochi E, Mochizuki M, et al. 2001. The presence of single nucleotide instability in human breast cancer cell lines. Cancer Res. 61:7739–7742.
   PubMed Web of Science ®Google Scholar
• Xiong XB, Huang Y, Lu WL, et al. 2005. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release. 107:262–275.
   PubMed Web of Science ®Google Scholar
• Yadav B, Taurin S, Rosengren RJ, et al. 2010. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem. 18:6701–6707.
   PubMed Web of Science ®Google Scholar
• Zaidi D, Singh N, Zareen Ahmad I, et al. 2011. Antiproliferative effects of curcumin plus centchroman in MCF-7 and MDA-MB-231 cells. Int J Pharm Pharm Sci. 3:212–216.
   Google Scholar
• Zhang DW, Fu M, Gao SH, et al. 2013. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. doi: 10.1155/2013/636053.
   Web of Science ®Google Scholar
• Zhou H, Yang Q, Wang X. 2014. Spectrometric study on the binding of curcumin with AOT: effect of micelle-to-vesicle transition. Food Chem. 161:136–141.
   PubMed Web of Science ®Google Scholar